Home/Filings/4/0001209191-19-052721
4//SEC Filing

Hanson Kristopher 4

Accession 0001209191-19-052721

CIK 0001169245other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 7:11 PM ET

Size

5.8 KB

Accession

0001209191-19-052721

Insider Transaction Report

Form 4
Period: 2019-10-07
Hanson Kristopher
Vice President, Head of Legal
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-10-07+66,00066,000 total
    Exercise: $4.17Exp: 2029-10-07Common Stock (66,000 underlying)
Footnotes (1)
  • [F1]One-fourth (1/4th) of the shares vest one year after the grant date; the balance of the shares shall vest in a series of 36 successive equal monthly installments measured from the first anniversary of the grant date, subject to the Reporting Person's continuous service as of each such date.

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001789970

Filing Metadata

Form type
4
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 7:11 PM ET
Size
5.8 KB